Health
newsGP – Mixed response to latest Solidarity trial COVID findings – RACGP
No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
News
No therapeutics in the trial – including remdesivir – were found to affect on mortality or illness duration, but some say there is hope.
While the results were disappointing, some experts say more detailed research is required. (Image: AAP)
Pre-print interim results from Solidarity, the world’s largest randomised control trial on COVID-19 therapeutics, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens have little or no effect on 28-day mortality or…
-
General19 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General24 hours agoOlder Aussies back increased superannuation tax
-
Noosa News21 hours agoTips to improve engagement – Proctor
-
Noosa News21 hours agoPolice appeal for information over suspected link in torture and murder cases